

Drs. Zeitels and Hillman of the Massachusetts General Hospital appeared in a segment about voice disorders on the Dr. Oz Show that aired in October of 2010. The segment included an endoscopy of a chronically hoarse audience member who was subsequently diagnosed as having voice abuse-related vocal cord pathology. Use the links below to view the segment:
Dr. Oz Show: Part 1 - click here
Dr. Oz Show: Part 2 - click here
Laryngeal Papillomatosis (RRP) is a devastating disease that affects tens of thousands of patients in the United States, more than half of whom are children. It is not unusual for patients to undergo 50 to 100 procedures. Over the past decade, the MGH researchers have created and established state-of-the-art treatment paradigms including the angiolytic KTP laser, and office-based laser surgery with local anesthesia. Most recently, they introduced and pioneered the use of the anti-angiogenesis drug Avastin for RRP.
The landmark research investigation demonstrating the effectiveness of Avastin with the KTP laser was published as a supplement to the Annals of Otology, Rhinology, and Laryngology in 2009. The MGH researchers are currently completing the first phase of an FDA approved study with promising early results. This research has transformed lives of the MGH patients treated thus far and was featured on Good Morning America and ABC World News. These shows explored former New York City Opera vocalist Mr. Michael Neimann's transformative treatment from the loss of his ability to sing to the resolution of the Papillomatosis and the restoration of his beautiful voice. "For me, the biggest gift I've had is losing it and then getting it back," said Neimann.
Good Morning America - click here
ABC World News - click here
A new treatment for vocal cord cancer developed by Dr. Steven Zeitels and collaborators at the Massachusetts General Hospital has been the subject of several media reports in the US and abroad. The breakthrough was reported by Dr. Timothy Johnson on ABC World News, and was featured in the New York Times and on National Public Radio.
Dr. Zeitels, the Eugene B. Casey Professor of Laryngeal Surgery and the Director of the Massachusetts General Hospital has been innovating vocal cord treatment for precancerous dysplasia and cancer for the past 20 years. This work has culminated in a new laser treatment for cancer, which has produced the best results to date. This treatment employs an angiolytic KTP laser which concentrates the laser energy in the cancer and optimally spares the normal vocal cord tissue to preserve and/or restore the patient's voice. The green light of the KTP laser is highly absorbed by red blood cells which enable it to selectively ablate the increased network of blood vessels (referred to as angiolysis) in cancerous tumors while preserving healthy tissue. The concept of treating cancer by diminishing its blood supply was established by Dr. Judah Folkman years ago.
Dr. Zeitels initiated this new treatment over 7 years ago after using angiolytic lasers for a number of years to treat precancerous dysplasia. The first patient to undergo this treatment was John Ward, PhD, the President of the VHI, who has been teaching and lecturing without difficulty ever since. The initial research investigation demonstrating the effectiveness for this work was published in the Annals of Otology, Rhinology, and Laryngology in 2008. Patients are seeking this cancer care from throughout the US and abroad and the MGH team has now treated over 100 patients. The MGH angiolytic laser treatment is an important and effective new option for treating vocal cord cancer since until now 90 percent of patients have received standard radiation
treatment which can damage normal vocal cord tissue and impair the voice.
ABC World News - click here
New York Times - click here
A unique article was done in Boston Magazine chronicling Dr. Zeitels' educational and professional career as a surgical innovator. A central theme of this piece was the exceptional care Zeitels provides for his patients which has led to their unparalleled appreciation and loyalty. Many of Zeitels' patients contributed personal comments and stories including Julie Andrews and Steven Tyler as well as VHI board members John Ward, Scott Solombrino, and Eli Tannenbaum. This insightful reporting captured the spirit of the VHI, which is based on the extraordinary commitment of Dr. Zeitels' patients to the cause of helping the large numbers of patients suffering from larynx and voice problems.
Boston Magazine - click here
After being interviewed by Matt Lauer on the Today Show on October 19, 2007, Steven Tyler and Dr. Steven Zeitels were featured on Sunday, October 21, on the National Geographic Channel (NGC), which presented the "Incredible Human Machine," This two-hour documentary is a journey through an ordinary and extraordinary day-in-the-life of the human machine. With stunning high-definition footage, radical scientific advances and powerful firsthand accounts, Incredible Human Machine plunged deep into the routine marvels of the human body.
Striking feats of medical advancements are demonstrated, including Dr. Zeitels' digitally-recorded laser surgery on Steven Tyler and real-time measurement of the rocker's vocal cords during a live concert. Aerosmith's lead singer Steven Tyler opens wide and gives us an intimate endoscopic look at how his famous pair of vocal cords holds up to the trauma of singing his signature song, "Dream On."
After vocal damage forced him to cancel part of the band's tour, a pioneering laser method of "zapping" the damaged blood vessels with a pulsed KTP laser allowed Tyler to start singing again. The real-time monitoring of Tyler's voice during the live concert was accomplished with new technology developed by a research team led by Dr. Hillman. These measurements reflected the tremendous strain that Tyler places
on his vocal system during a performance, often exceeding 110 decibels in loudness, with his vocal cords colliding more than 750,000 times during the 90 minute concert.

Dick Vitale, who was recently accepted into the College Basketball Hall of Fame for being its premier broadcaster, underwent vocal cord surgery by Dr. Zeitels
for precancerous dysplasia. Mr. Vitale was brought to Dr. Zeitels by his Otolaryngologist in Florida, Dr. Daniel Deems, because of the ground-breaking advancements by the MGH team in restoring voices, especially in those patients with precancerous and malignant vocal cord lesions. Mr. Vitale's treatment has been very successful and recently returned to announce the Duke - North Carolina game.
Later that week Drs. Hillman and Zeitels were hosted by Mr. Vitale and ESPN in Louisville for their contest with Georgetown. At that game, Vitale's voice was monitored with an invention developed by Dr. Hillman's research team and previously used to assess Steven Tyler for the National Geographic Channel documentary.
The events related to Mr. Vitale's voice surgery were covered extensively in sports pages throughout the country including the New York Times, Associated Press, and USA today. Zeitels was described by Vitale as "the Tom Brady of the voice surgery."
New York Times - click here
Americal Sportscaster Online - click here
(Reprinted with permission from The Wall Street Journal)
By Zachary M. Seward
Wednesday, August 16, 2006
Boston – STEVEN TYLER, the rock star and lead singer for Aerosmith, lay on an operating table at Massachusetts General Hospital in March, a thin laser snaking through his iconic mouth and down into his legendary pipes.
Nearly six months into a North American tour, a popped blood vessel on Mr. Tyler's right vocal cord had reduced his singing voice to a hoarse shrill and forced Aerosmith to cancel all 20 of its remaining concerts. The injury was a potential disaster for Mr. Tyler, whose hot-blooded, high-pitched tones have defined his 33-year career. Even the slightest tweak in his throat – the stiffening of a vocal cord or a change in its vibration – could have forever altered the sound of "Walk This Way," his signature tune.
